Related Experiment Video
Updated: Aug 19, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement
Raylene A Reimer1, Chantel T Debert, Jennifer L House
1Faculties of Kinesiology and Medicine, University of Calgary, 2500 University Drive NW, Calgary, AB, T2N 1N4, Canada. reimer@ucalgary.ca
Abstract:
While hormonal fluctuations during the menstrual cycle are known to affect energy intake, changes in dietary intake at menopause and specifically with hormone replacement therapy (HRT) are less well understood. Our objective was to assess dietary macro- and micronutrient intakes in premenopausal women (PEMW) in the luteal and follicular phases and postmenopausal women (PSMW) taking or not taking HRT. Serum estradiol and progesterone as well as resting energy expenditure (REE) and respiratory exchange ratio (RER) were measured. In the 9 PEMW, daily energy intake was 19% higher during the luteal versus follicular phase (2089+/-178 vs. 1752+/-158 kcal/day, p<0.05). The luteal phase was characterized by higher intake of total and saturated fat and a lower micronutrient density. In the 7 PSMW not taking HRT and 6 women taking HRT, there was no significant difference in total energy or macronutrient intake. Neither PEMW nor PSMW met national nutritional recommendations for folate, vitamin D, vitamin E and calcium. Serum progesterone levels were positively correlated with protein intake and negatively correlated with percent carbohydrate in the diet. REE was lower (p<0.05) in PSMW not taking HRT, but not in those taking HRT compared to young women. We confirm increased energy intake in the luteal phase in PEMW but found no difference in energy intake between PSMW taking or not taking HRT. While the quality of the diet in PSMW women was closer to national nutritional recommendations, several at risk nutrients that have been linked to health and disease were found in both groups.
Related Concept Videos
Menopause
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Regulation
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...